PRESS RELEASES
Royal Biologics Completes 100th Cyro Cord™ Case, Successfully Enrolls First Patient Into Diabetic Foot Ulcer Study
September 29, 2020
Royal Biologics Announces the Acquisition of FIBRINET
September 1, 2020
Royal Biologics Announces the Launch of Cryo-Cord™, the First Non-DMSO Viable Umbilical Cord Graft
January 21, 2020
Royal Biologics announces the launch of MAGNUS, a DMSO-free viable cellular bone allograft
January 8, 2020
Granite Creek Capital Partners, L.L.C. Announces an Investment in Royal Biologics
January 19, 2019
Royal Biologics Launches Maxx-Cell, the World’s Most Advanced Bone Marrow Aspiration Device
December 12, 2018
Royal Biologics Launches MAXX™-Fuse
Royal Biologics Launches Amnio-Maxx™, an Extracellular Matrix Product Derived From Human Amniotic Placental Tissue